Medtronic issues a warning letter to MiniMed Paradigm pump users after receiving reports that some patients had accidentally given themselves overdoses of insulin.
MASSDEVICE ON CALL — FDA medical device regulators reported this month that industry giant Medtronic (NYSE:MDT) issued a recall affecting nearly 560,000 units of its MiniMed Paradigm Infusion pumps.
Medtronic is not asking for the devices back, but is advising users to take extra care when programming their insulin dosage. The company has received reports that patients have accidentally programmed their insulin pumps to deliver the maximum bolus amount.
Sign up to get our free newsletters delivered straight to your inbox
The FDA report follows Medtronic's March 2014 letter to customers, in which the company cautioned users about accidental button pressing and advised that users always double-check their dosage on the pump's display.